Aspirin has the same side effects as hydroxychloroquine.
“Aspirin has the same side effects as hydroxychloroquine.”
complete bullshit; you’re either an ignorant moron or a liar, but either way, spreading that kind of misinformation could have serious health consequences for anyone foolish enough to believe your lies ...
aspirin:
Do not give this medicine to a child or teenager with a fever, flu symptoms, or chickenpox. Aspirin can cause Reye’s syndrome, a serious and sometimes fatal condition in children.
You should not use aspirin if you are allergic to it, or if you have:
a recent history of stomach or intestinal bleeding;
a bleeding disorder such as hemophilia; or
if you have ever had an asthma attack or severe allergic reaction after taking aspirin or an NSAID (non-steroidal anti-inflammatory drug) such as Advil, Motrin, Aleve, Orudis, Indocin, Lodine, Voltaren, Toradol, Mobic, Relafen, Feldene, and others.
To make sure this medicine is safe for you, tell your doctor if you have:
asthma or seasonal allergies;
stomach ulcers;
liver disease;
kidney disease;
a bleeding or blood clotting disorder;
gout; or
heart disease, high blood pressure, or congestive heart failure.
Taking aspirin during late pregnancy may cause bleeding in the mother or the baby during delivery. Tell your doctor if you are pregnant or plan to become pregnant.
Aspirin can pass into breast milk and may harm a nursing baby. You should not breastfeed while using this medicine.
hydroxychloroquine:
Overview
Side Effects
Dosage
Professional
Interactions
More
What is hydroxychloroquine?
Hydroxychloroquine is a quinoline medicine used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. This medicine is not effective against all strains of malaria.
Hydroxychloroquine is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus.
Important information
Taking hydroxychloroquine long-term or at high doses may cause irreversible damage to the retina of your eye. Stop taking this medicine and call your doctor at once if you have trouble focusing, if you see light streaks or flashes in your vision, or if you notice any swelling or color changes in your eyes.
Before using hydroxychloroquine, tell your doctor if you are allergic to any drugs, or if you have psoriasis, porphyria, liver disease, alcoholism, or glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Call a poison control center at once and then seek emergency medical attention if you think you have used too much of this medicine. An overdose of hydroxychloroquine can be fatal, especially in children.
Take hydroxychloroquine for the full prescribed length of time for malaria. Your symptoms may improve before the infection is completely cleared.
When treating lupus or arthritis, tell your doctor if your symptoms do not improve after 6 months of treatment.
Before taking this medicine
You should not use hydroxychloroquine if you are allergic to it.
Hydroxychloroquine should not be used for long-term treatment in children.
To make sure this medicine is safe for you, tell your doctor if you have:
a history of vision changes or damage to your retina caused by an anti-malaria medication;
heart disease, heart rhythm disorder (such as long QT syndrome);
diabetes;
a stomach disorder;
an allergy to quinine;
liver or kidney disease;
psoriasis;
alcoholism; or
a genetic enzyme disorder such as porphyria or glucose-6-phosphate dehydrogenase (G6PD) deficiency.
It is not known whether hydroxychloroquine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Malaria is more likely to cause death in a pregnant woman. If you are pregnant, talk with your doctor about the risks of traveling to areas where malaria is common.
It is not known whether hydroxychloroquine passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Hydroxychloroquine is not approved for use by anyone younger than 18 years old.
Postmarketing cases of life-threatening and fatal cardiomyopathy have been reported with use of Plaquenil and chloroquine. Patients may present with atrioventricular (AV) block, pulmonary hypertension, sick sinus syndrome or with cardiac complications. ECG findings may include AV, right or left bundle branch block.
— Signs or symptoms of cardiac compromise have appeared during acute and chronic treatment. Clinical monitoring for signs and symptoms of cardiomyopathy is advised, including use of appropriate diagnostic tools (eg, ECG) to monitor patients for cardiomyopathy during Plaquenil therapy.
— Chronic toxicity should be considered when conduction disorders (bundle branch block/AV heart block) or biventricular hypertrophy are diagnosed. If cardiotoxicity is suspected, prompt discontinuation of Plaquenil may prevent life-threatening complications.
— Plaquenil prolongs the QT interval. Ventricular arrhythmias and torsades de pointes have been reported in patients taking Plaquenil. Plaquenil should not be administered with other drugs that have the potential to prolong the QT interval.
• Plaquenil has been shown to cause severe hypoglycemia including loss of consciousness that could be life threatening in patients treated with or without antidiabetic medications.
— Patients treated with Plaquenil should be warned about the risk of hypoglycemia and the associated clinical signs and symptoms. Patients presenting with hypoglycemia symptoms during Plaquenil treatment should be evaluated.
• In addition, the Plaquenil label no longer lists the following as contraindications: presence of retinal or visual field changes attributable to any 4-aminoquinoline compound, or for long-term therapy in children.
• A new Drug Interactions section was added to the Plaquenil drug label with information regarding use with digoxin, insulin or diabetic drugs, drugs that prolong QT interval and other arrhythmogenic drugs, mefloquine and other drugs known to lower the convulsive threshold, antiepileptics, methotrexate, cyclosporine, Biltricide® (praziquantel), antacids and kaolin, cimetidine, and ampicillin.